GeneFerm Biotechnology Co

GeneFerm Biotechnology Co Inventory

The Inventory of GeneFerm Biotechnology Co (1796.TWO) as of Nov 14, 2026 is 190.23 M TWD. In the previous year, Inventory was 165.87 M TWD — a change of 14.69% (higher).

Inventory

190.23 MTWD

YoY

14.69%

Last updated:

Inventory of GeneFerm Biotechnology Co is 2025 190.23 M TWD. Inventory of GeneFerm Biotechnology Co was 2024 165.87 M TWD. It decreases by 14.69% higher compared to the previous year.

The GeneFerm Biotechnology Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
101.15 M TWD
Jan 1, 2019
99.19 M TWD
Jan 1, 2020
109.52 M TWD
Jan 1, 2021
114.83 M TWD
Jan 1, 2022
142.61 M TWD
Jan 1, 2023
155.43 M TWD
Jan 1, 2024
165.87 M TWD
Jan 1, 2025
190.23 M TWD
The GeneFerm Biotechnology Co Inventory history
YEARInventoryYoY
190.23 MTWD+14.69%
165.87 MTWD+6.71%
155.43 MTWD+9.00%
142.61 MTWD+24.19%
114.83 MTWD+4.86%
109.52 MTWD+10.41%
99.19 MTWD-1.94%
101.15 MTWD-15.04%
119.06 MTWD+50.73%
78.99 MTWD+31.83%
59.92 MTWD-33.31%
89.84 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co., Ltd. generates revenue through the manufacture and sale of health food and supplement products, including fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrate products. The company also offers related manufacturing services, health food design, and research and development services. Its primary customers are consumers seeking health-focused dietary supplements, with a focus on fermented and natural health food solutions. The firm targets health-conscious individuals and wellness-oriented markets through its product portfolio. The business model relies on direct sales of its branded health food products, leveraging the growing demand for natural and fermented dietary supplements. The company's R&D services support product innovation, while manufacturing services cater to partners requiring specialized production capabilities. Health food design services further enhance its offerings for clients in the wellness industry. GeneFerm's revenue streams are derived from both product sales and service-based offerings, with a strong emphasis on fermented health food solutions. The company's focus on medicinal mushrooms and lactic acid bacteria products differentiates its market position, appealing to consumers interested in natural health remedies and probiotic benefits. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

Inventory of GeneFerm Biotechnology Co is 190.23 M TWD in 2025.

Inventory of GeneFerm Biotechnology Co changed from 165.87 M TWD to 190.23 M TWD, representing a 14.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co